Please try another search
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Khoso Baluch | 63 | 2016 | CEO & Director |
Myron Kaplan | 75 | 2016 | Independent Chairman of the Board |
Steven W. Lefkowitz | 66 | 2013 | Independent Director |
Janet M. Dillione | 63 | 2015 | Independent Director |
Joseph Todisco | 47 | 2022 | CEO & Director |
Bruce Polsky | 69 | - | Member of Scientific Advisor Board |
Alan W. Dunton | 69 | 2019 | Independent Director |
Gregory Duncan | 58 | 2020 | Independent Director |
Hannah Newman | - | 2022 | Member of Scientific Advisory Board |
Sara Bonnes | - | 2022 | Member of Scientific Advisory Board |
Prayus Tailor | - | 2022 | Member of Scientific Advisory Board |
Robert A. Stewart | 55 | 2023 | Independent Director |
Jonathan Waitman | - | 2022 | Member of Scientific Advisory Board |
Stanley Crittenden | - | 2022 | Member of Scientific Advisory Board |
Saravanan Balamuthusamy | - | 2022 | Member of Scientific Advisory Board |
Aru Narendran | - | 2022 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review